NXL · Categories · Form 4

NXL - SEC Form 4 insider transactions

Nexalin Technology Inc. (NXL) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NXL

• 169d
  SEC Form 4 filed by CEO White Mark

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 169d
  SEC Form 4 filed by CFO Van Fleet Justin

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 169d
  SEC Form 4 filed by Chief Medical Officer Owens David

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 169d
  SEC Form 4 filed by Sr. VP - Quality - Regulatory Shelton Carolyn Hamby

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 169d
  SEC Form 4 filed by Director Kazden Alan

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 169d
  SEC Form 4 filed by Director Hu Ben

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 253d
  Large owner Osser Leonard was granted 83,333 shares, increasing direct ownership by 5% to 1,618,577 units (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 253d
  Chief Medical Officer Owens David was granted 36,459 shares, increasing direct ownership by 24% to 191,252 units (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 253d
  Director Hu Ben was granted 36,459 shares, increasing direct ownership by 11% to 377,095 units (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 253d
  Director Kazden Alan was granted 36,459 shares (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 271d
  SEC Form 4 filed by Sr. VP - Quality - Regulatory Shelton Carolyn Hamby

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 271d
  SEC Form 4 filed by Chief Medical Officer Owens David

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 271d
  SEC Form 4 filed by Large owner Elson Marilyn

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 324d
  SEC Form 4 filed by Large owner Elson Marilyn

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 468d
  SEC Form 4 filed by President and CEO White Mark

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 468d
  SEC Form 4 filed by Chief Medical Officer Owens David

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 616d
  Amendment: Large owner Elson Marilyn was granted 700,000 shares, increasing direct ownership by 84% to 1,535,244 units (SEC Form 4)

  4/A - Nexalin Technology, Inc. (0001527352) (Issuer)
• 616d
  Director Bernhard Leslie was granted 49,838 shares (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 616d
  Director Hu Ben was granted 175,000 shares, increasing direct ownership by 106% to 340,636 units (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 623d
  Large owner Elson Marilyn was granted 700,000 shares, increasing direct ownership by 84% to 1,535,244 units (SEC Form 4)

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 623d
  Amendment: SEC Form 4 filed by Large owner Elson Marilyn

  4/A - Nexalin Technology, Inc. (0001527352) (Issuer)
• 979d
  SEC Form 4 filed by White Mark

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 979d
  SEC Form 4 filed by Owens David

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 979d
  SEC Form 4 filed by Kazden Alan

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 979d
  SEC Form 4 filed by Elson Marilyn

  4 - Nexalin Technology, Inc. (0001527352) (Issuer)
• 1076d
  SEC Form 4 filed by Morad Rick (Amendment)

  4/A - Nexalin Technology, Inc. (0001527352) (Issuer)
• 1076d
  SEC Form 4 filed by White Mark (Amendment)

  4/A - Nexalin Technology, Inc. (0001527352) (Issuer)
• 1076d
  SEC Form 4 filed by Kazden Alan (Amendment)

  4/A - Nexalin Technology, Inc. (0001527352) (Issuer)

Other NXL categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends